Acta Haematologica · 2009 · 35 citations · 11 references
MedicineHematologyOncologyCytogeneticsHematologic OncologyHematopathologyClinical CytogeneticsHematologic DisordersHematologic MalignanciesHematopoietic NeoplasmsMultiple MyelomaPlasma Cell NeoplasmsComplex KaryotypesCytogenetics In Hematologic DiseaseLeukemia CytogeneticsLeukemia PathologyMultiple Myeloma Of BonePrimary Plasma Cell Leukemia
BACKGROUND/AIMS: The study was undertaken to understand the characteristic of plasma cell leukemia (PCL) in China. METHODS: We reviewed and compared medical data of 22 primary PCL, 9 secondary PCL and 461 multiple myeloma (MM) diagnosed at our institute from January 2000 to January 2008. RESULTS: The median onset ages of primary and secondary PCL patients were 49.5 and 56 years, respectively. PCL patients presented with a low peripheral blood plasmacytosis, extensive involvement of visceral organs and poor residual bone marrow function, without severe renal insufficiency. Seventeen of twenty-one PCL patients had abnormal karyotypes, mostly complex and hypodiploid or pseudodiploid. The deletion of 13q was frequent in primary and secondary PCL (57.1 and 42.9%, respectively). There was a significant difference in survival among primary PCL, secondary PCL and MM (median 14, 2 and 37 months, respectively, p = 0.0000). CONCLUSION: Overall, primary and secondary PCL are different disorders with distinct natural histories and survival.
11
Genetic aberrations and survival in plasma cell leukemia
Rodger E. Tiedemann, Natalia González-Paz, Robert A. Kyle et al. · Leukemia · 2008 · 344 citations
Plasma cell leukemia. Report on 17 cases
Robert A. Kyle · Archives of Internal Medicine · 1974 · 297 citations
Medicine, Hematology, Oncology +14